Mercer Global Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.9M | Buy |
33,714
+4,663
| +16% | +$409K | ﹤0.01% | 1150 |
|
|
2026
Q1 | $2.63M | Buy |
29,051
+3,112
| +12% | +$286K | ﹤0.01% | 1062 |
|
|
2025
Q4 | $2.33M | Sell |
25,939
-920
| -3% | -$87.2K | ﹤0.01% | 1039 |
|
|
2025
Q3 | $2.65M | Buy |
26,859
+3,752
| +16% | +$372K | ﹤0.01% | 923 |
|
|
2025
Q2 | $2.11M | Buy |
23,107
+4,338
| +23% | +$419K | ﹤0.01% | 865 |
|
|
2025
Q1 | $2.12M | Buy |
18,769
+1,357
| +8% | +$145K | ﹤0.01% | 821 |
|
|
2024
Q4 | $1.84M | Buy |
17,412
+8,083
| +87% | +$867K | ﹤0.01% | 859 |
|
|
2024
Q3 | $1M | Sell |
9,329
-426
| -4% | -$46.5K | ﹤0.01% | 1015 |
|
|
2024
Q2 | $1.05M | Sell |
9,755
-182
| -2% | -$21.5K | ﹤0.01% | 951 |
|
|
2024
Q1 | $1.31M | Buy |
9,937
+1,952
| +24% | +$244K | ﹤0.01% | 851 |
|
|
2023
Q4 | $972K | Sell |
7,985
-725
| -8% | -$80.9K | ﹤0.01% | 986 |
|
|
2023
Q3 | $977K | Sell |
8,710
-1,087
| -11% | -$138K | ﹤0.01% | 950 |
|
|
2023
Q2 | $1.43M | Sell |
9,797
-94
| -1% | -$12.8K | 0.01% | 828 |
|
|
2023
Q1 | $1.28M | Buy |
9,891
+567
| +6% | +$71.2K | 0.01% | 824 |
|
|
2022
Q4 | $1.19M | Buy |
9,324
+1,173
| +14% | +$136K | 0.01% | 848 |
|
|
2022
Q3 | $852K | Sell |
8,151
-1,587
| -16% | -$174K | 0.01% | 913 |
|
|
2022
Q2 | $1.02M | Sell |
9,738
-784
| -7% | -$93K | 0.01% | 831 |
|
|
2022
Q1 | $1.35M | Sell |
10,522
-2,173
| -17% | -$262K | 0.01% | 778 |
|
|
2021
Q4 | $1.57M | Buy |
12,695
+1,523
| +14% | +$199K | 0.01% | 709 |
|
|
2021
Q3 | $1.59M | Buy |
11,172
+917
| +9% | +$135K | 0.01% | 695 |
|
|
2021
Q2 | $1.6M | Buy |
10,255
+506
| +5% | +$82K | 0.01% | 652 |
|
|
2021
Q1 | $1.51M | Sell |
9,749
-121
| -1% | -$18.7K | 0.01% | 631 |
|
|
2020
Q4 | $1.48M | Sell |
9,870
-571
| -5% | -$80.6K | 0.02% | 503 |
|
|
2020
Q3 | $1.38M | Sell |
10,441
-2,995
| -22% | -$391K | 0.02% | 477 |
|
|
2020
Q2 | $1.56M | Sell |
13,436
-1,544
| -10% | -$178K | 0.03% | 376 |
|
|
2020
Q1 | $1.47M | Buy |
14,980
+919
| +7% | +$120K | 0.03% | 378 |
|
|
2019
Q4 | $2.04M | Buy |
14,061
+681
| +5% | +$94K | 0.04% | 335 |
|
|
2019
Q3 | $1.78M | Buy |
13,380
+1,291
| +11% | +$167K | 0.04% | 324 |
|
|
2019
Q2 | $1.38M | Buy |
12,089
+1,505
| +14% | +$176K | 0.04% | 376 |
|
|
2019
Q1 | $1.31M | Buy |
+10,584
| New | +$1.2M | 0.05% | 333 |
|
Other funds holding ZBH
Mercer Global Advisors's ZBH Position: Q2 2026 in Review
Mercer Global Advisors increased its Zimmer Biomet (ZBH) stake by 16% in Q2 2026, buying an estimated $409K and bringing the position to 33,714 shares worth $2.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1150.
Mercer Global Advisors first reported a position in ZBH in Q1 2019 and has held it in 30 quarters since. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Mercer Global Advisors held 33,714 shares of Zimmer Biomet worth $2.9M as of Q2 2026.
- Mercer Global Advisors bought 4,663 Zimmer Biomet shares in Q2 2026, an estimated $409K.
- Zimmer Biomet made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #1150 holding.
- Mercer Global Advisors first reported a position in Zimmer Biomet in Q1 2019 and has held it in 30 quarters since.
- 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.